Engaging biological oscillators through second messenger pathways permits emergence of a robust gastric slow-wave during peristalsis

Abstract

Peristalsis, the coordinated contraction—relaxation of the muscles of the stomach is important for normal gastric motility and is impaired in motility disorders. Coordinated electrical depolarizations that originate and propagate within a network of interconnected layers of interstitial cells of Cajal (ICC) and smooth muscle (SM) cells of the stomach wall as a slow-wave, underly peristalsis. Normally, the gastric slow-wave oscillates with a single period and uniform rostrocaudal lag, exhibiting network entrainment. Understanding of the integrative role of neurotransmission and intercellular coupling in the propagation of an entrained gastric slow-wave, important for understanding motility disorders, however, remains incomplete. Using a computational framework constituted of a novel gastric motility network (GMN) model we address the hypothesis that engaging biological oscillators (i.e., ICCs) by constitutive gap junction coupling mechanisms and enteric neural innervation activated signals can confer a robust entrained gastric slow-wave. We demonstrate that while a decreasing enteric neural innervation gradient that modulates the intracellular IP3 concentration in the ICCs can guide the aboral slow-wave propagation essential for peristalsis, engaging ICCs by recruiting the exchange of second messengers (inositol trisphosphate (IP3) and Ca2+) ensures a robust entrained longitudinal slow-wave, even in the presence of biological variability in electrical coupling strengths. Our GMN with the distinct intercellular coupling in conjunction with the intracellular feedback pathways and a rostrocaudal enteric neural innervation gradient allows gastric slow waves to oscillate with a moderate range of frequencies and to propagate with a broad range of velocities, thus preventing decoupling observed in motility disorders. Overall, the findings provide a mechanistic explanation for the emergence of decoupled slow waves associated with motility impairments of the stomach, offer directions for future experiments and theoretical work, and can potentially aid in the design of new interventional pharmacological and neuromodulation device treatments for addressing gastric motility disorders.

Recent Progress and Challenges of Implantable Biodegradable Biosensors

“…Using this clever approach, it is possible to monitor the evolution of salivary uric acid during appropriate drug treatment over four consecutive days. In the gastrointestinal tract, biodegradable origami-based robots that can be ingested into the stomach have been deployed that locomote to a desired location, remove a foreign body, patch a wound, deliver drugs, and eventually biodegrade [208,209]. Microrockets are similar microdevices that are composed of poly (aspartic acid) microtubes, thin Fe intermediate layers, and Zn cores.…”

Computational models of autonomic regulation in gastric motility: Progress, challenges, and future directions

“…The coupling is achieved through gap junction models which are typically Ohmic resistor in a network. A recent paper by Ahmed et al (2021) demonstrated this for gastric cells but the approach has been used in other biological modeling. For example, models of uterine electrophysiology used 10.3389/fnins.2023.1146097 a grid lattice network with gap junction coupling to explore organ level bioelectrical propagation (Xu et al, 2015).…”

Difference in 30-Day Readmission Rates After Laparoscopic Sleeve Gastrectomy Versus Laparoscopic Roux-En-Y Gastric Bypass: a Propensity Score Matched Study Using ACS NSQIP Data (2015–2019)

“…Although initially recommended through a 2-stage approach, LSG has later modified as a stand-alone one step procedure for the treatment of morbid obesity [11]. In LSG, the stomach [12,13] is reduced in capacity by removing two-thirds of the organ and suturing the remaining part using a stapling device. Several studies have supported that LSG showed similar weight loss and reduction in obesity-related comorbidities to LRYGB [14,15].…”